BRIGHTVIEW HLDGS DL-,01

BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV), the leading commercial landscaping services company in the United States, announced today that the Company's Board of Directors has declared a cash dividend of $8.9 million on its Series A Preferred Stock. The dividend represents payment for the period from March 31, 2025, to June 30, 2025, and will be paid on July 1, 2025, to holders of record as of June 15, 2025. Today's dividend announcement marks the sixth consecutive qu.» Mehr auf businesswire.com

-- BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 -- -- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- SAN DIEGO , June 11, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today announced that a study of SOLOSEC® (secnidazole) 2 g oral granules for recurrent bacterial vaginosis (BV) presented at the 2025 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting supports further development of SOLOSEC for the management of recurrent BV, a potential new indication. In a focused clinical study of 24 women with recurrent BV, once-weekly dosing with secnidazole oral granules (SOLOSEC) demonstrated efficacy matching or potentially surpassing outcomes of current CDC-recommended suppressive treatments.» Mehr auf prnewswire.com

BLUE BELL, Pa.--(BUSINESS WIRE)--BrightView Holdings, Inc. (NYSE: BV) (“BrightView”) today announced the pricing of an underwritten secondary offering by a selling stockholder affiliated with KKR & Co. Inc. (the “Selling Stockholder”) of 11,600,000 shares of common stock of BrightView pursuant to a registration statement filed by BrightView with the U.S. Securities and Exchange Commission (the “SEC”). No shares are being sold by BrightView. The Selling Stockholder will receive all of the pr.» Mehr auf businesswire.com